SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,591.73 |
| Enterprise Value ($M) | 2,378.92 |
| Book Value ($M) | 655.76 |
| Book Value / Share | 12.65 |
| Price / Book | 3.95 |
| NCAV ($M) | 625.45 |
| NCAV / Share | 12.06 |
| Price / NCAV | 4.14 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.08 |
| Return on Assets (ROA) | -0.16 |
| Return on Equity (ROE) | -0.18 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 62.09 |
| Current Ratio | 62.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 658.67 |
| Assets | 688.98 |
| Liabilities | 33.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 8.08 |
| Operating Income | -72.98 |
| Net Income | -58.29 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -50.58 |
| Cash from Investing | -41.19 |
| Cash from Financing | 59.55 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Ra Capital Management, L.p. | 19.99 | 22.18 | |
| 13D/A | Avalon Ventures XI, L.P. | 17.10 | -9.89 | |
| 13G/A | Biotechnology Value Fund L P | 9.90 | 11.51 | |
| 13G/A | Citadel Advisors Llc | 6.80 | ||
| 13G/A | EcoR1 Capital, LLC | 0.00 | -100.00 | |
| 13G/A | Campbell David Alan | 5.30 | 6.94 | |
| 13G/A | Fmr Llc | 10.12 | -16.67 | |
| 13G/A | Bregua Corp | 8.30 | 2.16 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 102,251 | 636,420 | 16.07 | |
| 73,330 | 820,610 | 8.94 | |
| 173,256 | 344,241 | 50.33 | |
| 167,384 | 327,374 | 51.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ITOS – iTeos Therapeutics, Inc. | IVVD – Invivyd, Inc. |
| IXHL – Incannex Healthcare Inc. | KALV – KalVista Pharmaceuticals, Inc. |
| KOD – Kodiak Sciences Inc. |
Financial data and stock pages provided by
Fintel.io